150 related articles for article (PubMed ID: 37887552)
1. Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients.
Juríčková V; Fayette D; Jonáš J; Fajnerová I; Kozák T; Horáček J
Curr Oncol; 2023 Oct; 30(10):9028-9038. PubMed ID: 37887552
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment associated with Hodgkin's lymphoma and chemotherapy.
Fayette D; Juríčková V; Kozák T; Mociková H; Gaherová L; Fajnerová I; Horáček J
Neurosci Lett; 2023 Feb; 797():137082. PubMed ID: 36693557
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment in hodgkin lymphoma survivors.
Trachtenberg E; Mashiach T; Ben Hayun R; Tadmor T; Fisher T; Aharon-Peretz J; Dann EJ
Br J Haematol; 2018 Sep; 182(5):670-678. PubMed ID: 29974933
[TBL] [Abstract][Full Text] [Related]
4. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary.
Magyari F; Virga I; Simon Z; Miltényi Z; Illés A; Kósa K; Ivánka T; Berecz R; Égerházi A; Illés Á
Support Care Cancer; 2022 Jun; 30(6):5249-5258. PubMed ID: 35274189
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors.
Mariegaard J; Wenstrup J; Lim KZM; Bidstrup PE; von Heymann A; Johansen C; Knudsen GM; Law I; Specht L; Stenbæk DS
Support Care Cancer; 2021 Jun; 29(6):3319-3328. PubMed ID: 33118105
[TBL] [Abstract][Full Text] [Related]
7. The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients.
Lycke M; Lefebvre T; Pottel L; Pottel H; Ketelaars L; Stellamans K; Eygen KV; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
J Psychosoc Oncol; 2017; 35(6):741-757. PubMed ID: 28816636
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological profiles of breast cancer and brain tumor cohorts in Northeast Ontario, Canada.
Mariani M; Collins MWG
Support Care Cancer; 2018 Nov; 26(11):3801-3809. PubMed ID: 29774475
[TBL] [Abstract][Full Text] [Related]
9. Association between psychological distress, subjective cognitive complaints and objective neuropsychological functioning in brain tumor patients.
Pranckeviciene A; Deltuva VP; Tamasauskas A; Bunevicius A
Clin Neurol Neurosurg; 2017 Dec; 163():18-23. PubMed ID: 29035741
[TBL] [Abstract][Full Text] [Related]
10. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
Feldman L; Lapin B; Busch RM; Bautista JF
Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment in patients with psoriasis: A matched case-control study.
Innamorati M; Quinto RM; Lester D; Iani L; Graceffa D; Bonifati C
J Psychosom Res; 2018 Feb; 105():99-105. PubMed ID: 29332640
[TBL] [Abstract][Full Text] [Related]
12. Premorbid adjustment predictors of cognitive dysfunction in schizophrenia.
Stefanatou P; Karatosidi CS; Tsompanaki E; Kattoulas E; Stefanis NC; Smyrnis N
Psychiatry Res; 2018 Sep; 267():249-255. PubMed ID: 29940456
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Changes Related to Cancer Therapy.
Vannorsdall TD
Med Clin North Am; 2017 Nov; 101(6):1115-1134. PubMed ID: 28992858
[TBL] [Abstract][Full Text] [Related]
14. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
[TBL] [Abstract][Full Text] [Related]
15. Cancer-related cognitive impairment and wellbeing in patients with newly diagnosed aggressive lymphoma compared to population norms and healthy controls: an exploratory study.
Gates P; Dhillon HM; Krishnasamy M; Wilson C; Gough K
Support Care Cancer; 2024 Mar; 32(4):238. PubMed ID: 38512692
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
Fayette D; Gahérová Ľ; Móciková H; Marková J; Kozák T; Horáček J
Klin Onkol; 2017; 30(2):93-99. PubMed ID: 28397504
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairments in patients with persistent symptoms attributed to Lyme disease.
Berende A; Agelink van Rentergem J; Evers AWM; Ter Hofstede HJM; Vos FJ; Kullberg BJ; Kessels RPC
BMC Infect Dis; 2019 Oct; 19(1):833. PubMed ID: 31590634
[TBL] [Abstract][Full Text] [Related]
18. Biological and psychological predictors of cognitive function in breast cancer patients before surgery.
Aspelund SG; Halldorsdottir T; Agustsson G; Sigurdardottir Tobin HR; Wu LM; Amidi A; Johannsdottir KR; Lutgendorf SK; Telles R; Daly HF; Sigurdardottir K; Valdimarsdottir HB; Baldursdottir B
Support Care Cancer; 2024 Jan; 32(1):88. PubMed ID: 38185720
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study.
Gates P; Gough K; Dhillon H; Wilson C; Hawkes E; Dore V; Perchyonok Y; Rowe CC; Walker AK; Vardy JL; de Ruiter M; Krishnasamy M
BMJ Open; 2020 Sep; 10(9):e038312. PubMed ID: 32994248
[TBL] [Abstract][Full Text] [Related]
20. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
